secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartBeam, Inc. (BEAT)
CIK:        0001779372
Form:       8-K
Filed at:   2021-12-27T23:59:59+00:00
Accession:  0001779372-21-000003
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HeartBeam appoints Alan Baumel as COO effective Dec 20, 2021
------------------------------------------------------------

- Annual salary of $200,000, bonus eligibility post-IPO, and option for 1% of post-IPO shares.
- Bring 35+ years MedTech experience; previously SVP at Bardy Diagnostics (Hillrom) and roles at Gore, Medtronic, Boston Scientific-acquired firms.
- Will lead product development, manufacturing, quality, and regulatory affairs to accelerate commercialization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779372/000177937221000003/0001779372-21-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779372/000177937221000003/form8k-12202021.htm
  HTML page:      https://secwatch.observer/filing/0001779372-21-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer